Shock, Hemorrhagic
12
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
8.3%
1 terminated out of 12 trials
85.7%
-0.9% vs benchmark
33%
4 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
Predictors of In-Hospital Mortality in Severe Abdominal Trauma
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Empiric Calcium in Massive Transfusion
Feasibility of Evaluating XSTAT Use in the Prehospital Setting
Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma
Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)
Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission
Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Polydatin Injectable (HW6) for Shock Treatment